Fluence  ||| S:0 E:8 ||| JJ
field  ||| S:8 E:14 ||| NN
optimization  ||| S:14 E:27 ||| NN
for  ||| S:27 E:31 ||| IN
noise  ||| S:31 E:37 ||| NN
and  ||| S:37 E:41 ||| CC
dose  ||| S:41 E:46 ||| NN
objectives  ||| S:46 E:57 ||| NNS
in  ||| S:57 E:60 ||| IN
CT  ||| S:60 E:63 ||| NNP
Selecting  ||| S:63 E:73 ||| NNP
the  ||| S:73 E:77 ||| DT
appropriate  ||| S:77 E:89 ||| JJ
imaging  ||| S:89 E:97 ||| NN
technique  ||| S:97 E:107 ||| NN
in  ||| S:107 E:110 ||| IN
computed  ||| S:110 E:119 ||| JJ
tomography  ||| S:119 E:130 ||| NNS
( ||| S:130 E:131 ||| -LRB-
CT ||| S:131 E:133 ||| NNP
)  ||| S:133 E:135 ||| -RRB-
inherently  ||| S:135 E:146 ||| RB
involves  ||| S:146 E:155 ||| VBZ
balancing  ||| S:155 E:165 ||| VBG
the  ||| S:165 E:169 ||| DT
tradeoff  ||| S:169 E:178 ||| NN
between  ||| S:178 E:186 ||| IN
image  ||| S:186 E:192 ||| NN
quality  ||| S:192 E:200 ||| NN
and  ||| S:200 E:204 ||| CC
imaging  ||| S:204 E:212 ||| JJ
dose ||| S:212 E:216 ||| NN
.  ||| S:216 E:218 ||| .
Modulation  ||| S:218 E:229 ||| NNP
of  ||| S:229 E:232 ||| IN
the  ||| S:232 E:236 ||| DT
x-ray  ||| S:236 E:242 ||| JJ
fluence  ||| S:242 E:250 ||| JJ
field ||| S:250 E:255 ||| NN
,  ||| S:255 E:257 ||| ,
laterally  ||| S:257 E:267 ||| VBG
across  ||| S:267 E:274 ||| IN
the  ||| S:274 E:278 ||| DT
beam ||| S:278 E:282 ||| NN
,  ||| S:282 E:284 ||| ,
and  ||| S:284 E:288 ||| CC
independently  ||| S:288 E:302 ||| RB
for  ||| S:302 E:306 ||| IN
each  ||| S:306 E:311 ||| DT
projection ||| S:311 E:321 ||| NN
,  ||| S:321 E:323 ||| ,
may  ||| S:323 E:327 ||| MD
potentially  ||| S:327 E:339 ||| RB
meet  ||| S:339 E:344 ||| VB
user-prescribed ||| S:344 E:359 ||| JJ
,  ||| S:359 E:361 ||| ,
regional  ||| S:361 E:370 ||| JJ
image  ||| S:370 E:376 ||| NN
quality  ||| S:376 E:384 ||| NN
objectives ||| S:384 E:394 ||| NNS
,  ||| S:394 E:396 ||| ,
while  ||| S:396 E:402 ||| IN
reducing  ||| S:402 E:411 ||| VBG
radiation  ||| S:411 E:421 ||| NN
to  ||| S:421 E:424 ||| TO
the  ||| S:424 E:428 ||| DT
patient ||| S:428 E:435 ||| NN
.  ||| S:435 E:437 ||| .
The  ||| S:437 E:441 ||| DT
proposed  ||| S:441 E:450 ||| JJ
approach ||| S:450 E:458 ||| NN
,  ||| S:458 E:460 ||| ,
called  ||| S:460 E:467 ||| VBD
fluence  ||| S:467 E:475 ||| JJ
field  ||| S:475 E:481 ||| NN
modulated  ||| S:481 E:491 ||| VBD
CT  ||| S:491 E:494 ||| NNP
( ||| S:494 E:495 ||| -LRB-
FFMCT ||| S:495 E:500 ||| NNP
) ||| S:500 E:501 ||| -RRB-
,  ||| S:501 E:503 ||| ,
parallels  ||| S:503 E:513 ||| VBZ
the  ||| S:513 E:517 ||| DT
approach  ||| S:517 E:526 ||| NN
commonly  ||| S:526 E:535 ||| RB
used  ||| S:535 E:540 ||| VBN
in  ||| S:540 E:543 ||| IN
intensity-modulated  ||| S:543 E:563 ||| JJ
radiation  ||| S:563 E:573 ||| NN
therapy  ||| S:573 E:581 ||| NN
( ||| S:581 E:582 ||| -LRB-
IMRT ||| S:582 E:586 ||| NNP
) ||| S:586 E:587 ||| -RRB-
,  ||| S:587 E:589 ||| ,
except  ||| S:589 E:596 ||| IN
image  ||| S:596 E:602 ||| NN
quality  ||| S:602 E:610 ||| NN
plans  ||| S:610 E:616 ||| NNS
replace  ||| S:616 E:624 ||| VBP
the  ||| S:624 E:628 ||| DT
dose  ||| S:628 E:633 ||| NN
plans  ||| S:633 E:639 ||| NNS
of  ||| S:639 E:642 ||| IN
IMRT ||| S:642 E:646 ||| NNP
.  ||| S:646 E:648 ||| .
This  ||| S:648 E:653 ||| DT
work  ||| S:653 E:658 ||| NN
studies  ||| S:658 E:666 ||| NNS
the  ||| S:666 E:670 ||| DT
potential  ||| S:670 E:680 ||| JJ
noise  ||| S:680 E:686 ||| NN
and  ||| S:686 E:690 ||| CC
dose  ||| S:690 E:695 ||| NN
benefits  ||| S:695 E:704 ||| NNS
of  ||| S:704 E:707 ||| IN
FFMCT  ||| S:707 E:713 ||| NNP
via  ||| S:713 E:717 ||| IN
objective  ||| S:717 E:727 ||| NN
driven  ||| S:727 E:734 ||| VBN
optimization  ||| S:734 E:747 ||| VBN
of  ||| S:747 E:750 ||| IN
fluence  ||| S:750 E:758 ||| JJ
fields ||| S:758 E:764 ||| NNS
.  ||| S:764 E:766 ||| .
Experiments  ||| S:766 E:778 ||| NNS
were  ||| S:778 E:783 ||| VBD
carried  ||| S:783 E:791 ||| VBN
out  ||| S:791 E:795 ||| RP
in  ||| S:795 E:798 ||| IN
simulation ||| S:798 E:808 ||| NN
.  ||| S:808 E:810 ||| .
Image  ||| S:810 E:816 ||| NN
quality  ||| S:816 E:824 ||| NN
plans  ||| S:824 E:830 ||| NNS
were  ||| S:830 E:835 ||| VBD
defined  ||| S:835 E:843 ||| VBN
by  ||| S:843 E:846 ||| IN
specifying  ||| S:846 E:857 ||| VBG
signal-to-noise  ||| S:857 E:873 ||| JJ
ratio  ||| S:873 E:879 ||| NN
( ||| S:879 E:880 ||| -LRB-
SNR ||| S:880 E:883 ||| NNP
)  ||| S:883 E:885 ||| -RRB-
criteria  ||| S:885 E:894 ||| NNS
for  ||| S:894 E:898 ||| IN
regions  ||| S:898 E:906 ||| NNS
of  ||| S:906 E:909 ||| IN
interest  ||| S:909 E:918 ||| NN
( ||| S:918 E:919 ||| -LRB-
ROIs ||| S:919 E:923 ||| NNP
)  ||| S:923 E:925 ||| -RRB-
in  ||| S:925 E:928 ||| IN
simulated  ||| S:928 E:938 ||| JJ
cylindrical  ||| S:938 E:950 ||| NN
and  ||| S:950 E:954 ||| CC
oblong  ||| S:954 E:961 ||| JJ
water  ||| S:961 E:967 ||| NN
phantoms ||| S:967 E:975 ||| NN
,  ||| S:975 E:977 ||| ,
and  ||| S:977 E:981 ||| CC
an  ||| S:981 E:984 ||| DT
anthropomorphic  ||| S:984 E:1000 ||| JJ
phantom  ||| S:1000 E:1008 ||| NN
with  ||| S:1008 E:1013 ||| IN
bone ||| S:1013 E:1017 ||| NN
,  ||| S:1017 E:1019 ||| ,
air ||| S:1019 E:1022 ||| NN
,  ||| S:1022 E:1024 ||| ,
and  ||| S:1024 E:1028 ||| CC
water  ||| S:1028 E:1034 ||| NN
equivalent  ||| S:1034 E:1045 ||| NN
regions ||| S:1045 E:1052 ||| NNS
.  ||| S:1052 E:1054 ||| .
X-ray  ||| S:1054 E:1060 ||| NN
fluence  ||| S:1060 E:1068 ||| NN
field  ||| S:1068 E:1074 ||| NN
patterns  ||| S:1074 E:1083 ||| NNS
were  ||| S:1083 E:1088 ||| VBD
generated  ||| S:1088 E:1098 ||| VBN
using  ||| S:1098 E:1104 ||| VBG
a  ||| S:1104 E:1106 ||| DT
simulated  ||| S:1106 E:1116 ||| JJ
annealing  ||| S:1116 E:1126 ||| JJ
optimization  ||| S:1126 E:1139 ||| JJ
method  ||| S:1139 E:1146 ||| NN
that  ||| S:1146 E:1151 ||| WDT
attempts  ||| S:1151 E:1160 ||| VBZ
to  ||| S:1160 E:1163 ||| TO
achieve  ||| S:1163 E:1171 ||| VB
the  ||| S:1171 E:1175 ||| DT
spatially-dependent  ||| S:1175 E:1195 ||| JJ
prescribed  ||| S:1195 E:1206 ||| JJ
SNR  ||| S:1206 E:1210 ||| NN
criteria  ||| S:1210 E:1219 ||| NNS
in  ||| S:1219 E:1222 ||| IN
the  ||| S:1222 E:1226 ||| DT
phantoms  ||| S:1226 E:1235 ||| NN
while  ||| S:1235 E:1241 ||| IN
limiting  ||| S:1241 E:1250 ||| VBG
dose  ||| S:1250 E:1255 ||| NN
( ||| S:1255 E:1256 ||| -LRB-
to  ||| S:1256 E:1259 ||| TO
the  ||| S:1259 E:1263 ||| DT
volume  ||| S:1263 E:1270 ||| NN
or  ||| S:1270 E:1273 ||| CC
subvolumes ||| S:1273 E:1283 ||| CD
) ||| S:1283 E:1284 ||| -RRB-
.  ||| S:1284 E:1286 ||| .
The  ||| S:1286 E:1290 ||| DT
resulting  ||| S:1290 E:1300 ||| VBG
SNR  ||| S:1300 E:1304 ||| NNP
and  ||| S:1304 E:1308 ||| CC
dose  ||| S:1308 E:1313 ||| NN
distributions  ||| S:1313 E:1327 ||| NNS
were  ||| S:1327 E:1332 ||| VBD
analyzed  ||| S:1332 E:1341 ||| VBN
and  ||| S:1341 E:1345 ||| CC
compared  ||| S:1345 E:1354 ||| VBN
to  ||| S:1354 E:1357 ||| TO
results  ||| S:1357 E:1365 ||| NNS
using  ||| S:1365 E:1371 ||| VBG
a  ||| S:1371 E:1373 ||| DT
bowtie  ||| S:1373 E:1380 ||| JJ
filtered  ||| S:1380 E:1389 ||| JJ
fluence  ||| S:1389 E:1397 ||| JJ
field ||| S:1397 E:1402 ||| NN
.  ||| S:1402 E:1404 ||| .
Compared  ||| S:1404 E:1413 ||| VBN
to  ||| S:1413 E:1416 ||| TO
using  ||| S:1416 E:1422 ||| VBG
a  ||| S:1422 E:1424 ||| DT
fixed  ||| S:1424 E:1430 ||| JJ
bowtie  ||| S:1430 E:1437 ||| JJ
filtered  ||| S:1437 E:1446 ||| JJ
fluence ||| S:1446 E:1453 ||| NN
,  ||| S:1453 E:1455 ||| ,
FFMCT  ||| S:1455 E:1461 ||| NNP
achieved  ||| S:1461 E:1470 ||| VBD
superior  ||| S:1470 E:1479 ||| JJ
agreement  ||| S:1479 E:1489 ||| NN
with  ||| S:1489 E:1494 ||| IN
the  ||| S:1494 E:1498 ||| DT
target  ||| S:1498 E:1505 ||| NN
image  ||| S:1505 E:1511 ||| NN
quality  ||| S:1511 E:1519 ||| NN
objectives ||| S:1519 E:1529 ||| NNS
,  ||| S:1529 E:1531 ||| ,
and  ||| S:1531 E:1535 ||| CC
resulted  ||| S:1535 E:1544 ||| VBD
in  ||| S:1544 E:1547 ||| IN
integral  ||| S:1547 E:1556 ||| JJ
dose  ||| S:1556 E:1561 ||| NN
reductions  ||| S:1561 E:1572 ||| NNS
ranging  ||| S:1572 E:1580 ||| VBG
from  ||| S:1580 E:1585 ||| IN
39  ||| S:1585 E:1588 ||| CD
to  ||| S:1588 E:1591 ||| TO
52 ||| S:1591 E:1593 ||| CD
% ||| S:1593 E:1594 ||| NN
.  ||| S:1594 E:1596 ||| .
Prioritizing  ||| S:1596 E:1609 ||| JJ
dose  ||| S:1609 E:1614 ||| NN
constraints  ||| S:1614 E:1626 ||| NNS
for  ||| S:1626 E:1630 ||| IN
specific  ||| S:1630 E:1639 ||| JJ
regions  ||| S:1639 E:1647 ||| NNS
of  ||| S:1647 E:1650 ||| IN
interest  ||| S:1650 E:1659 ||| NN
resulted  ||| S:1659 E:1668 ||| VBD
in  ||| S:1668 E:1671 ||| IN
a  ||| S:1671 E:1673 ||| DT
preferential  ||| S:1673 E:1686 ||| JJ
reduction  ||| S:1686 E:1696 ||| NN
of  ||| S:1696 E:1699 ||| IN
dose  ||| S:1699 E:1704 ||| NN
to  ||| S:1704 E:1707 ||| TO
those  ||| S:1707 E:1713 ||| DT
regions  ||| S:1713 E:1721 ||| NNS
with  ||| S:1721 E:1726 ||| IN
some  ||| S:1726 E:1731 ||| DT
tradeoff  ||| S:1731 E:1740 ||| NN
in  ||| S:1740 E:1743 ||| IN
SNR ||| S:1743 E:1746 ||| NNP
,  ||| S:1746 E:1748 ||| ,
particularly  ||| S:1748 E:1761 ||| RB
where  ||| S:1761 E:1767 ||| WRB
the  ||| S:1767 E:1771 ||| DT
target  ||| S:1771 E:1778 ||| NN
low  ||| S:1778 E:1782 ||| JJ
dose  ||| S:1782 E:1787 ||| NN
regions  ||| S:1787 E:1795 ||| NNS
overlapped  ||| S:1795 E:1806 ||| VBN
with  ||| S:1806 E:1811 ||| IN
regions  ||| S:1811 E:1819 ||| NNS
where  ||| S:1819 E:1825 ||| WRB
high  ||| S:1825 E:1830 ||| JJ
SNR  ||| S:1830 E:1834 ||| NNP
was  ||| S:1834 E:1838 ||| VBD
prescribed ||| S:1838 E:1848 ||| VBN
.  ||| S:1848 E:1850 ||| .
The  ||| S:1850 E:1854 ||| DT
method  ||| S:1854 E:1861 ||| NN
appeared  ||| S:1861 E:1870 ||| VBD
fairly  ||| S:1870 E:1877 ||| RB
robust  ||| S:1877 E:1884 ||| JJ
under  ||| S:1884 E:1890 ||| IN
increased  ||| S:1890 E:1900 ||| JJ
complexity  ||| S:1900 E:1911 ||| NN
and  ||| S:1911 E:1915 ||| CC
heterogeneity  ||| S:1915 E:1929 ||| NN
of  ||| S:1929 E:1932 ||| IN
the  ||| S:1932 E:1936 ||| DT
object  ||| S:1936 E:1943 ||| JJ
structure ||| S:1943 E:1952 ||| NN
.  ||| S:1952 E:1954 ||| .
These  ||| S:1954 E:1960 ||| DT
results  ||| S:1960 E:1968 ||| NNS
support  ||| S:1968 E:1976 ||| VBP
that  ||| S:1976 E:1981 ||| IN
FFMCT  ||| S:1981 E:1987 ||| NNP
has  ||| S:1987 E:1991 ||| VBZ
the  ||| S:1991 E:1995 ||| DT
potential  ||| S:1995 E:2005 ||| JJ
to  ||| S:2005 E:2008 ||| TO
meet  ||| S:2008 E:2013 ||| VB
prescribed  ||| S:2013 E:2024 ||| VBN
image  ||| S:2024 E:2030 ||| NN
quality  ||| S:2030 E:2038 ||| NN
objectives ||| S:2038 E:2048 ||| NNS
,  ||| S:2048 E:2050 ||| ,
while  ||| S:2050 E:2056 ||| IN
decreasing  ||| S:2056 E:2067 ||| VBG
radiation  ||| S:2067 E:2077 ||| NN
exposure  ||| S:2077 E:2086 ||| NN
to  ||| S:2086 E:2089 ||| TO
the  ||| S:2089 E:2093 ||| DT
patient ||| S:2093 E:2100 ||| NN
.  ||| S:2100 E:2102 ||| .
Tradeoffs  ||| S:2102 E:2112 ||| NNS
between  ||| S:2112 E:2120 ||| IN
SNR  ||| S:2120 E:2124 ||| NNP
and  ||| S:2124 E:2128 ||| CC
dose  ||| S:2128 E:2133 ||| NN
may  ||| S:2133 E:2137 ||| MD
not  ||| S:2137 E:2141 ||| RB
be  ||| S:2141 E:2144 ||| VB
eliminated ||| S:2144 E:2154 ||| VBN
,  ||| S:2154 E:2156 ||| ,
but  ||| S:2156 E:2160 ||| CC
might  ||| S:2160 E:2166 ||| MD
be  ||| S:2166 E:2169 ||| VB
more  ||| S:2169 E:2174 ||| RBR
efficiently  ||| S:2174 E:2186 ||| RB
managed  ||| S:2186 E:2194 ||| VBN
using  ||| S:2194 E:2200 ||| VBG
FFMCT ||| S:2200 E:2205 ||| NNP
.  ||| S:2205 E:2207 ||| .
